Ikarian Capital’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-140,687
| Closed | -$1.98M | – | 90 |
|
|
2024
Q1 | $1.98M | Sell |
140,687
-234,120
| -62% | -$3.3M | 0.22% | 44 |
|
|
2023
Q4 | $2.88M | Hold |
374,807
| – | – | 0.27% | 31 |
|
|
2023
Q3 | $2.8M | Sell |
374,807
-204,583
| -35% | -$1.53M | 0.34% | 26 |
|
|
2023
Q2 | $4.83M | Sell |
579,390
-290,000
| -33% | -$2.42M | 0.77% | 19 |
|
|
2023
Q1 | $11.6M | Buy |
869,390
+194,214
| +29% | +$2.58M | 2.62% | 3 |
|
|
2022
Q4 | $10.1M | Sell |
675,176
-24,264
| -3% | -$361K | 2.43% | 8 |
|
|
2022
Q3 | $6.32M | Buy |
699,440
+107,317
| +18% | +$970K | 1.26% | 9 |
|
|
2022
Q2 | $1.78M | Buy |
592,123
+499,900
| +542% | +$1.5M | 0.32% | 33 |
|
|
2022
Q1 | $619K | Buy |
92,223
+4,643
| +5% | +$31.2K | 0.08% | 83 |
|
|
2021
Q4 | $473K | Hold |
87,580
| – | – | 0.07% | 99 |
|
|
2021
Q3 | $775K | Sell |
87,580
-1,136
| -1% | -$10.1K | 0.05% | 103 |
|
|
2021
Q2 | $1.12M | Sell |
88,716
-53,450
| -38% | -$677K | 0.09% | 105 |
|
|
2021
Q1 | $2.46M | Buy |
142,166
+33,833
| +31% | +$586K | 0.08% | 92 |
|
|
2020
Q4 | $1.39M | Buy |
+108,333
| New | +$1.39M | 0.06% | 84 |
|